Salarius Pharmaceuticals, Inc. (SLRX) Earnings
|
Expand Research on SLRX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -472.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/25  |
Q225 | N/A | -$1.02 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | -$1.43 | N/A | N/A | N/A | N/A | N/A |  | | Details | |
| 11/16/22 | Q322 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/5/22 | Q222 | -$0.07 | -$0.11 | +$0.04 | $571.39K | N/A | N/A | | | Details | |
| 5/11/23 | Q122 | -$2.23 | -$0.11 | -$2.12 | N/A | N/A | N/A | | | Details |
